Larvol Delta - Effects-of-enrichment-strategies-on-outcome-of-adrecizumab-treatment-in-septic-shock-Posthoc-analyses-of-the-phase-II-adrenomedullin-and-outcome-in-septic-shock-2-trial

enibarcimab (HAM 8101) - Adrenomed

http://www.ncbi.nlm.nih.gov/pubmed/36530868

Dec 20, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next